MK-8776, a novel chk1 kinase inhibitor, radiosensitizes p53-defective human tumor cells

Por Bridges, Kathleen A., Chen, Xingxing, Liu, Huifeng, Rock, Crosby, Buchholz, Thomas A., Shumway, Stuart D., Skinner, Heath D., Meyn, Raymond E.
Publicado no Oncotarget (2016)

Patterns-of-failure guided biological target volume definition for Head and Neck cancer patients: FDG-PET and dosimetric analysis of dose escalation candidate subregions

Por Mohamed, Abdallah S. R., Cardenas, Carlos E, Garden, Adam S., Awan, Musaddiq J., Rock, Crosby D., Westergaard, Sarah A., Gunn, G. Brandon, Belal, Abdelaziz M., El-Gowily, Ahmed G., Lai, Stephen Y., Rosenthal, David I., Fuller, Clifton D., Aristophanous, Michalis
Publicado no Radiother Oncol (2017)

Long-term patient reported outcomes following radiation therapy for oropharyngeal cancer: cross-sectional assessment of a prospective symptom survey in patients ≥65 years old

Por Eraj, Salman A., Jomaa, Mona K., Rock, Crosby D., Mohamed, Abdallah S. R., Smith, Blaine D., Smith, Joshua B., Browne, Theodora, Cooksey, Luke C., Williams, Bowman, Temple, Brandi, Preston, Kathryn E., Aymar, Jeremy M., Gross, Neil D., Weber, Randal S., Hessel, Amy C., Ferrarotto, Renata, Phan, Jack, Sturgis, Erich M., Hanna, Ehab Y., Frank, Steven J., Morrison, William H., Goepfert, Ryan P., Lai, Stephen Y., Rosenthal, David I., Mendoza, Tito R., Cleeland, Charles S., Hutcheson, Kate A., Fuller, Clifton D., Garden, Adam S., Gunn, G. Brandon
Publicado no Radiat Oncol (2017)